RhinoCyte

Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury.

Get a Demo and See the Full Profile

Get a demo today to see profiles of RhinoCyte plus 6037 other startups.

Learn More About RhinoCyte

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More